We are live on ! Find out more
SKYE icon

Skye Bioscience
SKYE

73 hedge funds and large institutions have $71.3M invested in Skye Bioscience in 2024 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 29 increasing their positions, 10 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

190% more repeat investments, than reductions

Existing positions increased: 29 | Existing positions reduced: 10

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

7% less first-time investments, than exits

New positions opened: 13 | Existing positions closed: 14

1% less funds holding

Funds holding: 74 → 73 (-1)

1.72% less ownership

Funds ownership: 84.81% → 83.09% (-1.7%)

29% less capital invested

Capital invested by funds: $101M → $71.3M (-$29.3M)

Holders
73
Holders Change
-1
Holders Change %
-1.35%
% of All Funds
0.96%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
13
Increased
29
Reduced
10
Closed
14
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
B
Braidwell
Connecticut
+$3.45M
2
SSA
Schonfeld Strategic Advisors
New York
+$1.94M
3
UBS Group
UBS Group
Switzerland
+$140K
4
Deutsche Bank
Deutsche Bank
Germany
+$134K
5
BlackRock
BlackRock
New York
+$111K

Top Sellers

Rank Fund Capital Flow
1
Point72 Asset Management
Point72 Asset Management
Connecticut
-$1.63M
2
AIC
AWM Investment Company
New York
-$1.56M
3
Millennium Management
Millennium Management
New York
-$1.54M
4
VCIM
Velan Capital Investment Management
Georgia
-$825K
5
ACM
Altium Capital Management
New York
-$736K
Name Holding Trade Value Shares
Change 		Change in
Stake
Legal & General Group
51
Legal & General Group
United Kingdom
$4.21K – – –
California State Teachers Retirement System (CalSTRS)
52
California State Teachers Retirement System (CalSTRS)
California
$3.53K – – –
Russell Investments Group
53
Russell Investments Group
United Kingdom
$2.4K +$3.38K +808 +2,072%
AB
54
Amalgamated Bank
New York
$2K – – –
RS
55
R Squared
Hong Kong
$1.44K +$2.13K +510 New
SCM
56
Sterling Capital Management
North Carolina
$1.39K +$1.85K +442 +884%
FDCDDQ
57
Federation des caisses Desjardins du Quebec
Quebec, Canada
$144 – – –
MCM
58
MAI Capital Management
Ohio
$91 +$134 +32 New
TWC
59
TD Waterhouse Canada
Ontario, Canada
$71 +$96 +23 +1,150%
NFSG
60
Newbridge Financial Services Group
Florida
$51 – – –
Osaic Holdings
61
Osaic Holdings
Arizona
$45 – – –
BCMLT
62
Beacon Capital Management LLC (Tennessee)
Tennessee
$23 – – –
HI
63
Harbour Investments
Wisconsin
$20 – – –
IA
64
IFP Advisors
Florida
$8 – – –
PMFA
65
Plante Moran Financial Advisors
Michigan
$8 – – –
PS
66
Principal Securities
Iowa
$6 – – –
GSWM
67
Golden State Wealth Management
California
$6 +$8 +2 New
CAS
68
Coppell Advisory Solutions
Texas
$4 +$17 +4 New
PP
69
PFS Partners
New Jersey
$3 – – –
TAM
70
Tucker Asset Management
Colorado
$3 – – –
NA
71
NewEdge Advisors
Louisiana
$3 +$4 +1 New
Point72 Asset Management
72
Point72 Asset Management
Connecticut
– -$1.63M -416,424 Closed
AIC
73
AWM Investment Company
New York
– -$1.56M -400,000 Closed
Millennium Management
74
Millennium Management
New York
– -$1.54M -394,386 Closed
VCIM
75
Velan Capital Investment Management
Georgia
– -$825K -211,071 Closed
1 2
3
4

SKYE Hedge Fund Activity: Q4 2024 in Review

73 of the 7,593 institutional investors tracked by Wall St. Rank reported a position in Skye Bioscience (SKYE) for Q4 2024, worth a combined $71.3M — down 29% from $101M a quarter earlier.

Sellers outnumbered buyers: 14 funds closed out of SKYE and 13 opened new positions — a net loss of 1 holder — while 10 trimmed existing stakes and 29 added.

The largest buyer was Braidwell, opening a new position worth an estimated $3.45M. The largest seller was Point72 Asset Management, exiting entirely with an estimated $1.63M sold.

  • 73 institutional investors held Skye Bioscience (SKYE) as of Q4 2024, down from 74 in Q3 2024.
  • Funds reported $71.3M of Skye Bioscience stock for Q4 2024, down 29% quarter-over-quarter.
  • 13 funds opened new Skye Bioscience positions in Q4 2024 and 14 closed out, a net change of -1 holder.
  • The largest Skye Bioscience buyer in Q4 2024 was Braidwell, an estimated $3.45M added.
  • The largest Skye Bioscience seller in Q4 2024 was Point72 Asset Management, an estimated $1.63M sold.

Based on aggregated 13F filings for Q4 2024.